Learn more

Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    111,362
  • Filing trend
    ⇩ 100.0%
About

Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE URALSKIJ NAUCHNO ISSLEDOVATELSKIJ INSTITUT OKHRA, Universität Heidelberg and UNIV CATTOLICA SACRO CUORE.

Patent filings in countries

World map showing Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuiss patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 7
#2 United States 4
#3 Canada 2
#4 Netherlands 2

Patent filings per year

Chart showing Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuiss patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ruers Theodoor Jacques Marie 4
#2 Bernards Rene 4
#3 Raaben Matthijs 2
#4 Blomen Vincent Arthur 2
#5 Brockmann Markus 2
#6 Kho Esther 2
#7 Brummelkamp Thijn Reinout 2
#8 Jae Lucas Tilmann 2
#9 Sterenborg Henricus Josephus Cornelus Maria 2
#10 Van Buuren Marit Martha 1

Latest patents

Publication Filing date Title
WO2017204626A1 Combination therapy - combined map2k4/map3k1 and mek/erk inhibition
WO2017142399A1 Method, apparatus and software for detection and localization of hidden defects in optically diffuse media
WO2017099591A1 Treatment of inhibitor resistant braf-mutant cancers
CA2987383A1 Assays to identify genetic elements affecting phenotype
WO2016148573A1 Methods and means for subtyping invasive lobular breast cancer
NL2016273B1 Method, apparatus and software for detection and localization of hidden defects in optically diffuse media.
US2017319101A1 Magnetic marker, location detection system, introducer and method
CA2953277A1 Means and methods for determining t cell recognition
NL2013366B1 Adenylation enzyme inhibitors.